Literature DB >> 9056796

Retrospective study of reasons for improved survival in patients with breast cancer in east Anglia: earlier diagnosis or better treatment.

D Stockton1, T Davies, N Day, J McCann.   

Abstract

OBJECTIVES: To investigate the recent fall in mortality from breast cancer in England and Wales, and to determine the relative contributions of improvements in treatment and earlier detection of tumours.
DESIGN: Retrospective study of all women with breast cancer registered by the East Anglian cancer registry and diagnosed between 1982 and 1989.
SUBJECTS: 3965 patients diagnosed 1982-5 compared with 4665 patients diagnosed 1986-9, in three age groups 0-49, 50-64, > or = 65 years, with information on stage at diagnosis and survival. MAIN OUTCOME MEASURES: Three year relative survival rates by time period, age group, and stage; relative hazard ratios for each time period and age group derived from Cox's proportional hazards model, adjusted for single year of age and stage.
RESULTS: Survival improved in the later time period, although there was little stage specific improvement. The proportion of early stage tumours increased especially in the 50-64 year age group, and adjustment for stage accounted for over half of the improvement in survival in women aged under 65 years.
CONCLUSION: Over half of the drop in mortality in women aged under 65 years seems to be attributable to earlier detection of tumours, which has been observed since the mid-1980s. This could have resulted from an increase in breast awareness predating the start of the breast screening programme.

Entities:  

Mesh:

Year:  1997        PMID: 9056796      PMCID: PMC2126011          DOI: 10.1136/bmj.314.7079.472

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  21 in total

1.  Survival and reduction in mortality from breast cancer. Impact of mammographic screening is not clear.

Authors:  M Baum
Journal:  BMJ       Date:  2000-12-09

2.  Epidemiological aspects of cancer screening in Germany.

Authors:  Nikolaus Becker
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-14       Impact factor: 4.553

3.  The influence of socioeconomic markers on the association between fine particulate matter and hospital admissions for respiratory conditions among children.

Authors:  Poh-Sin Yap; Susan Gilbreath; Cynthia Garcia; Nargis Jareen; Bryan Goodrich
Journal:  Am J Public Health       Date:  2013-02-14       Impact factor: 9.308

4.  How many deaths have been avoided through improvements in cancer survival?

Authors:  M A Richards; D Stockton; P Babb; M P Coleman
Journal:  BMJ       Date:  2000-04-01

5.  Misconceptions about breast lumps and delayed medical presentation in urban breast cancer patients.

Authors:  Garth H Rauscher; Carol Estwing Ferrans; Karen Kaiser; Richard T Campbell; Elizabeth E Calhoun; Richard B Warnecke
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-03       Impact factor: 4.254

6.  Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality.

Authors:  R G Blanks; S M Moss; C E McGahan; M J Quinn; P J Babb
Journal:  BMJ       Date:  2000-09-16

Review 7.  The role of cancer registries in cancer control.

Authors:  Donald Maxwell Parkin
Journal:  Int J Clin Oncol       Date:  2008-05-08       Impact factor: 3.402

8.  Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2017-05-18       Impact factor: 79.321

9.  Imputation of missing values of tumour stage in population-based cancer registration.

Authors:  Nora Eisemann; Annika Waldmann; Alexander Katalinic
Journal:  BMC Med Res Methodol       Date:  2011-09-19       Impact factor: 4.615

10.  Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study.

Authors:  Mette Kalager; Tor Haldorsen; Michael Bretthauer; Geir Hoff; Steinar O Thoresen; Hans-Olov Adami
Journal:  Breast Cancer Res       Date:  2009-07-06       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.